Truist Financial started coverage on Genmab shares, and TD Cowen raised rating and price target for the company, which trades on Nasdaq.
3 reports, 2 independent
Updated Thu 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial started coverage on Genmab shares, and TD Cowen raised rating and price target for the company, which trades on Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley set a price target for Genmab, following an upgrade by TD Cowen.1 source
Truist Financial started coverage on Genmab shares, and TD Cowen raised rating and price target.1 source
Keep exploring
The entities involved
-
Genmab
Danish healthcare company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- Corning saw rating changes and price target adjustments from Morgan Stanley and Truist Financial, alongside increased shareholding by the Czech National Bank.
- Retailers like Kroger and Walmart intensify competition in the grocery market, while Erste Group and Truist Financial report market movements.
-
TD Cowen
American investment bank
Related events
- Truist Financial cut its price target and lowered its rating, while TD Cowen raised its target price, with MarketBeat aggregating consensus ratings.
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Bank of America raised its target price on Morgan Stanley shares, while TD Cowen assumed coverage and MarketBeat reported analyst ratings.
- TD Cowen initiated coverage on Citizens Financial Group shares.
- Truist Financial raised its target price on ArcBest, while Citigroup initiated coverage and Stephens upgraded the stock rating.